Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | geranylgeranyl transferase type I beta subunit | 0.0268 | 0.3158 | 0.4405 |
Brugia malayi | Protein prenyltransferase alpha subunit repeat containing protein | 0.0374 | 0.6414 | 0.6414 |
Loa Loa (eye worm) | hypothetical protein | 0.0374 | 0.6414 | 0.6691 |
Echinococcus granulosus | jun protein | 0.0491 | 1 | 1 |
Loa Loa (eye worm) | hypoxia-induced factor 1 | 0.0245 | 0.2444 | 0.2549 |
Brugia malayi | hypothetical protein | 0.0266 | 0.3078 | 0.3078 |
Brugia malayi | hypoxia-induced factor 1 | 0.0245 | 0.2444 | 0.2444 |
Onchocerca volvulus | 0.0385 | 0.6755 | 0.5 | |
Echinococcus granulosus | geranylgeranyl transferase type I beta subunit | 0.0268 | 0.3158 | 0.3158 |
Leishmania major | farnesyltransferase beta subunit | 0.0166 | 0 | 0.5 |
Echinococcus multilocularis | geranylgeranyl transferase type I beta subunit | 0.0268 | 0.3158 | 0.3158 |
Schistosoma mansoni | hypothetical protein | 0.0399 | 0.7169 | 1 |
Schistosoma mansoni | geranylgeranyl transferase type I beta subunit | 0.0268 | 0.3158 | 0.4405 |
Giardia lamblia | Rab geranylgeranyltransferase | 0.0374 | 0.6414 | 1 |
Entamoeba histolytica | geranylgeranyl transferase beta subunit | 0.0268 | 0.3158 | 0.4924 |
Trichomonas vaginalis | protein farnesyltransferase alpha subunit, putative | 0.0374 | 0.6414 | 1 |
Loa Loa (eye worm) | prenyltransferase and squalene oxidase repeat family protein | 0.0268 | 0.3158 | 0.3295 |
Trypanosoma cruzi | protein farnesyltransferase, putative | 0.0166 | 0 | 0.5 |
Echinococcus multilocularis | protein farnesyltransferase alpha subunit | 0.0374 | 0.6414 | 0.6414 |
Schistosoma mansoni | protein farnesyltransferase alpha subunit | 0.0374 | 0.6414 | 0.8946 |
Plasmodium vivax | prenyltransferase alpha subunit, putative | 0.0374 | 0.6414 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0491 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0266 | 0.3078 | 0.3211 |
Brugia malayi | hypothetical protein | 0.0385 | 0.6755 | 0.6755 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0491 | 1 | 1 |
Loa Loa (eye worm) | prenyltransferase alpha subunit repeat containing protein | 0.0374 | 0.6414 | 0.6691 |
Entamoeba histolytica | protein farnesyltransferase alpha subunit, putative | 0.0374 | 0.6414 | 1 |
Schistosoma mansoni | jun-related protein | 0.0399 | 0.7169 | 1 |
Trichomonas vaginalis | protein farnesyltransferase alpha subunit, putative | 0.0374 | 0.6414 | 1 |
Brugia malayi | Prenyltransferase and squalene oxidase repeat family protein | 0.0268 | 0.3158 | 0.3158 |
Trypanosoma cruzi | protein farnesyltransferase, putative | 0.0166 | 0 | 0.5 |
Trichomonas vaginalis | geranylgeranyl transferase type I beta subunit, putative | 0.0268 | 0.3158 | 0.4924 |
Echinococcus granulosus | protein farnesyltransferase alpha subunit | 0.0374 | 0.6414 | 0.6414 |
Trypanosoma brucei | protein farnesyltransferase beta subunit | 0.0166 | 0 | 0.5 |
Trichomonas vaginalis | protein farnesyltransferase alpha subunit/RAB geranylgeranyl transferase alpha subunit, putative | 0.0277 | 0.3426 | 0.5342 |
Echinococcus multilocularis | jun protein | 0.0491 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0477 | 0.9586 | 1 |
Trichomonas vaginalis | protein farnesyltransferase alpha subunit/RAB geranylgeranyl transferase alpha subunit, putative | 0.0374 | 0.6414 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0277 | 0.3426 | 1 |
Plasmodium falciparum | protein farnesyltransferase subunit alpha | 0.0374 | 0.6414 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 22 % | Ability of the compound to inhibit phenylquinone induced writhing, in rat at dose 25 mg/Kg administered per orally | ChEMBL. | 6607999 |
Inhibition (functional) | = 35 % | Ability of the compound to inhibit Carrageenan-induced paw edema in rat at dose 20 mg/Kg administered per orally | ChEMBL. | 6607999 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.